Rhumbline Advisers Increases Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Rhumbline Advisers raised its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 15.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,836 shares of the company’s stock after purchasing an additional 6,275 shares during the period. Rhumbline Advisers owned 0.12% of Viemed Healthcare worth $376,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the business. Barclays PLC grew its position in shares of Viemed Healthcare by 342.3% during the 3rd quarter. Barclays PLC now owns 53,439 shares of the company’s stock valued at $392,000 after acquiring an additional 41,358 shares during the period. JPMorgan Chase & Co. lifted its stake in Viemed Healthcare by 151.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company’s stock worth $724,000 after purchasing an additional 59,538 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Viemed Healthcare by 748.2% in the 3rd quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock worth $795,000 after purchasing an additional 95,706 shares in the last quarter. SG Americas Securities LLC lifted its stake in Viemed Healthcare by 193.1% in the 4th quarter. SG Americas Securities LLC now owns 35,579 shares of the company’s stock worth $285,000 after purchasing an additional 23,442 shares in the last quarter. Finally, Wasatch Advisors LP raised its position in shares of Viemed Healthcare by 19.6% during the 3rd quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after buying an additional 303,277 shares during the period. 74.24% of the stock is owned by institutional investors and hedge funds.

Viemed Healthcare Stock Up 0.5 %

VMD stock opened at $7.50 on Friday. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $10.00. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm’s 50 day moving average price is $8.01 and its 200-day moving average price is $8.18. The firm has a market cap of $292.03 million, a PE ratio of 27.78 and a beta of 1.50.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.